Jennifer Byrne
A nationally recognized leader and champion of the Clinical Research as a Care Option (CRAACO) movement, Jennifer Byrne’s career has been devoted to building teams and driving change in pursuit of a more efficient, more impactful approach to clinical research. In 2018, she founded Javara with a vision to revolutionize the industry by accelerating access to clinical trials for patients, sponsors, and healthcare systems alike. By bridging the gap between clinical research and clinical care, Javara enables more patients to participate through trusted point-of-care access and support. Prior to Javara, Jennifer served as CEO of PMG Research and founded Greater Gift (501(c)3). She has been recognized as a PM360 ELITE, CenterWatch Top 20 Innovator, PharmaVOICE Woman of Influence, TBJ Outstanding Woman in Business and two-time TBJ Power Player, among others. Jennifer is a graduate of Texas A&M University.